124 related articles for article (PubMed ID: 27380353)
1. Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD--Reply.
Faisy C; Heming N;
JAMA; 2016 Jul; 316(1):100-1. PubMed ID: 27380353
[No Abstract] [Full Text] [Related]
2. Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD.
Mishra S; Azim A; Baronia A
JAMA; 2016 Jul; 316(1):100. PubMed ID: 27380352
[No Abstract] [Full Text] [Related]
3. Acetazolamide and Invasive Mechanical Ventilation for Patients With COPD.
Contou D; de Prost N; Mekontso Dessap A
JAMA; 2016 Jul; 316(1):99-100. PubMed ID: 27380350
[No Abstract] [Full Text] [Related]
4. Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial.
Faisy C; Meziani F; Planquette B; Clavel M; Gacouin A; Bornstain C; Schneider F; Duguet A; Gibot S; Lerolle N; Ricard JD; Sanchez O; Djibre M; Ricome JL; Rabbat A; Heming N; Urien S; Esvan M; Katsahian S;
JAMA; 2016 Feb; 315(5):480-8. PubMed ID: 26836730
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of acetazolamide for reversal of metabolic alkalosis in weaning COPD patients from mechanical ventilation.
Faisy C; Mokline A; Sanchez O; Tadié JM; Fagon JY
Intensive Care Med; 2010 May; 36(5):859-63. PubMed ID: 20217045
[TBL] [Abstract][Full Text] [Related]
6. Acetazolamide: a second wind for a respiratory stimulant in the intensive care unit?
Heming N; Urien S; Faisy C
Crit Care; 2012 Aug; 16(4):318. PubMed ID: 22866939
[TBL] [Abstract][Full Text] [Related]
7. Acetazolamide improves oxygenation in patients with respiratory failure and metabolic alkalosis.
Gulsvik R; Skjørten I; Undhjem K; Holø L; Frostad A; Saure EW; Lejlic V; Humerfelt S; Hansen G; Bruun Wyller T
Clin Respir J; 2013 Oct; 7(4):390-6. PubMed ID: 23578004
[TBL] [Abstract][Full Text] [Related]
8. Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patients.
Heming N; Faisy C; Urien S
Crit Care; 2011; 15(5):R213. PubMed ID: 21917139
[TBL] [Abstract][Full Text] [Related]
9. Single versus multiple doses of acetazolamide for metabolic alkalosis in critically ill medical patients: a randomized, double-blind trial.
Mazur JE; Devlin JW; Peters MJ; Jankowski MA; Iannuzzi MC; Zarowitz BJ
Crit Care Med; 1999 Jul; 27(7):1257-61. PubMed ID: 10446816
[TBL] [Abstract][Full Text] [Related]
10. Effects of early administration of acetazolamide on the duration of mechanical ventilation in patients with chronic obstructive pulmonary disease or obesity-hypoventilation syndrome with metabolic alkalosis. A randomized trial.
Rialp Cervera G; Raurich Puigdevall JM; Morán Chorro I; Martín Delgado MC; Heras la Calle G; Mas Serra A; Vallverdú Perapoch I
Pulm Pharmacol Ther; 2017 Jun; 44():30-37. PubMed ID: 28286047
[TBL] [Abstract][Full Text] [Related]
11. Carbon dioxide production during acetazolamide and medroxyprogesterone treatment.
Cole RP
Eur Respir J; 2003 Apr; 21(4):733; author reply 734. PubMed ID: 12762366
[No Abstract] [Full Text] [Related]
12. Acetazolamide Use in Severe Chronic Obstructive Pulmonary Disease. Pros and Cons.
Adamson R; Swenson ER
Ann Am Thorac Soc; 2017 Jul; 14(7):1086-1093. PubMed ID: 28622013
[TBL] [Abstract][Full Text] [Related]
13. Carbon dioxide elimination after acetazolamide in patients with chronic obstructive pulmonary disease and metabolic alkalosis.
Krintel JJ; Haxholdt OS; Berthelsen P; Brøckner J
Acta Anaesthesiol Scand; 1983 Jun; 27(3):252-4. PubMed ID: 6410668
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with acetazolamide and medroxyprogesterone in chronic obstructive pulmonary disease patients.
Wagenaar M; Vos PJ; Heijdra YF; Teppema LJ; Folgering HT
Eur Respir J; 2002 Nov; 20(5):1130-7. PubMed ID: 12449165
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacodynamic modeling and simulation of the respiratory effect of acetazolamide in decompensated COPD patients.
Heming N; Urien S; Fulda V; Meziani F; Gacouin A; Clavel M; Planquette B; Faisy C
PLoS One; 2014; 9(1):e86313. PubMed ID: 24466018
[TBL] [Abstract][Full Text] [Related]
16. Acetazolamide and breathing. Does a clinical dose alter peripheral and central CO(2) sensitivity?
Teppema LJ; Dahan A
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1592-7. PubMed ID: 10556126
[TBL] [Abstract][Full Text] [Related]
17. Effect of acetazolamide on post-NIV metabolic alkalosis in acute exacerbated COPD patients.
Fontana V; Santinelli S; Internullo M; Marinelli P; Sardo L; Alessandrini G; Borgognoni L; Ferrazza AM; Bonini M; Palange P
Eur Rev Med Pharmacol Sci; 2016; 20(1):37-43. PubMed ID: 26813451
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
Leaf DE; Goldfarb DS
J Appl Physiol (1985); 2007 Apr; 102(4):1313-22. PubMed ID: 17023566
[TBL] [Abstract][Full Text] [Related]
19. [Comparative clinical studies on the diuretic p-chlorbenzolsulfonamidothiazolsulfonamide (Siccamide) with acetazolamide].
Rein H; Thiele W
Klin Wochenschr; 1968 Jul; 46(14):751-9. PubMed ID: 5698721
[No Abstract] [Full Text] [Related]
20. Evaluating off-label uses of acetazolamide.
Van Berkel MA; Elefritz JL
Am J Health Syst Pharm; 2018 Apr; 75(8):524-531. PubMed ID: 29626002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
